Inventor · disambiguated record
Nadya I. Tarasova
Also filed as: TARASOVA NADYA · TARASOVA NADYA I
13 granted patents·6 pending applications·41 citations·filing 1999–2022
86Inventor score
Top patents by PatentIndex Score
19 records- 0179US11167012B2Peptide inhibition of CCR3-mediated diseases or conditionsUNIV ILLINOIS·Filed 2019·Granted Nov 9, 2021·2 cites·3 claims
- 0276US7105488B1G protein-coupled receptor antagonistsUS HEALTH·Filed 1999·Granted Sep 12, 2006·31 cites·7 claims
- 0373US8008316B2Azonafide derived tumor and cancer targeting compoundsUS HEALTH·Filed 2007·Granted Aug 30, 2011·2 cites·39 claims
- 0472US9056891B2Synthetic peptide inhibitors of Wnt pathwayUS HEALTH·Filed 2013·Granted Jun 16, 2015·3 cites·23 claims
- 0563US9540427B2Peptide-based stat inhibitorTARASOVA NADYA I·Filed 2008·Granted Jan 10, 2017·0 cites·14 claims
- 0657US7517849B1Inhibition of ABC transporters by transmembrane domain analogsUS HEALTH·Filed 2000·Granted Apr 14, 2009·3 cites·39 claims
- 0754US9326950B2Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugsTARASOVA NADYA I·Filed 2007·Granted May 3, 2016·0 cites·15 claims
- 0853US8198402B2Smoothened polypeptides and methods of useTARASOVA NADYA·Filed 2007·Granted Jun 12, 2012·0 cites·24 claims
- 0952US10363286B2Peptide inhibition of CCR3-mediated diseases or conditionsUNIV ILLINOIS·Filed 2017·Granted Jul 30, 2019·0 cites·10 claims
- 1052US9328142B2Lipopeptide inhibitors of RAS oncoproteinsTARASOVA NADYA I·Filed 2012·Granted May 3, 2016·0 cites·22 claims
- 1152US2024317732A1A new molecular scaffold for targeting hrpn13THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2022·Application pending·0 cites
- 1252US2013316957A1Smoothened polypeptides and methods of useUS GOV HEALTH & HUMAN SERV·Filed 2013·Application pending·0 cites
- 1349US8546524B2Smoothened polypeptides and methods of useTARASOVA NADYA·Filed 2012·Granted Oct 1, 2013·0 cites·46 claims
- 1446US2011195911A1Synthetic analogs of the juxtamembrane domain of igf1r and uses thereofUS HEALTH·Filed 2009·Application pending·0 cites
- 1546US2017204148A1Peptide-based stat inhibitorTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVIC·Filed 2017·Application pending·0 cites
- 1645US2005171014A1Conjugates of ligand linker and cytotoxic agent and related composition and methods of useUS GOV HEALTH & HUMAN SERV·Filed 2003·Application pending·0 cites
- 1741US9475839B2Peptide-based inhibitor of interleukin-10 or interferon-gamma signalingTARASOVA NADYA I·Filed 2011·Granted Oct 25, 2016·0 cites·20 claims
- 1840US2016151456A1Lipopeptide inhibitors of ras oncoproteinsUS HEALTH·Filed 2016·Application pending·0 cites
- 1929US10512673B2Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous diseaseUS HEALTH·Filed 2016·Granted Dec 24, 2019·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →